Literature DB >> 9001841

Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care.

J E Bailey1, M D Lee, G W Somes, R L Graham.   

Abstract

Antihypertensive medication noncompliance is common and leads to substantial morbidity for patients and increased health care costs for managed-care organizations. A retrospective cohort study using pharmacy prescription profiles to estimate noncompliance was conducted to determine important risk factors for patient noncompliance with antihypertensive therapy for Medicaid enrollees participating in a managed-care plan. The pharmacy and claims data for 1395 patients with uncomplicated hypertension who were enrollees of Tennessee's Medicaid managed-care program were analyzed to determine the frequency of the enrollees' failure to obtain timely antihypertensive medication refills (hereafter referred to as refill failure) and to identify the predictors of refill failure. Overall, refill failure occurred in 33% of 7413 refill opportunities studied, whereas refill failure occurred in 32% of the cases in which medication was dosed once daily and in 35% of the cases in which medication was dosed more than once daily. For patients taking alpha-blockers, there was a significantly lower rate of refill failure (11.0%) than for patients taking angiotensin-converting enzyme inhibitors, direct vasodilators, and thiazide diuretics. Patients taking calcium channel blockers, had a significantly lower rate of refill failure (38.5%) than for patients taking thiazide diuretics (45.5%). Younger age, medication class, multiple-daily dosing regimen, and fewer provider visits were all found to be significant independent predictors of refill failure, whereas gender and regimen complexity were not significant predictors in this population. Health care systems planning pharmacy-based interventions to improve patient compliance with antihypertensive medication for patients in a Medicaid managed-care program can expect to encounter high levels of refill failure and may want to target enrollee subgroups by age, medication class, or dosing regimen for intensive intervention efforts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9001841     DOI: 10.1016/s0149-2918(96)80080-4

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  17 in total

Review 1.  Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

Authors:  K A Payne; S Esmonde-White
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

Review 2.  Association between medication regimen complexity and pharmacotherapy adherence: a systematic review.

Authors:  Laís Lessa Pantuzza; Maria das Graças Braga Ceccato; Micheline Rosa Silveira; Luane Mendes Ribeiro Junqueira; Adriano Max Moreira Reis
Journal:  Eur J Clin Pharmacol       Date:  2017-08-04       Impact factor: 2.953

3.  Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study.

Authors:  Maribel Salas; Catarina I Kiefe; Pamela J Schreiner; Yongin Kim; Lucia Juarez; Sharina D Person; O Dale Williams
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

Review 4.  Factors associated with antihypertensive medication non-adherence: a systematic review.

Authors:  D M van der Laan; P J M Elders; C C L M Boons; J J Beckeringh; G Nijpels; J G Hugtenburg
Journal:  J Hum Hypertens       Date:  2017-06-29       Impact factor: 3.012

5.  Predictors of self-reported noncompliance with antihypertensive drug treatment: a prospective cohort study.

Authors:  J Grégoire; Jocelyne Moisan; Remi Guibert; Antonio Ciampi; Alain Milot
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

6.  Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease.

Authors:  Dong-Churl Suh; Simu K Thomas; Elmira Valiyeva; Stephen Arcona; Lien Vo
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular risk.

Authors:  Hueiming Liu; Anushka Patel; Alex Brown; Sandra Eades; Noel Hayman; Stephen Jan; Ian Ring; Greg Stewart; Andrew Tonkin; Tarun Weeramanthri; Vicki Wade; Anthony Rodgers; Tim Usherwood; Bruce Neal; David Peiris; Hugh Burke; Christopher Reid; Alan Cass
Journal:  BMC Public Health       Date:  2010-08-05       Impact factor: 3.295

8.  Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors.

Authors:  Philip S Wang; Rhonda L Bohn; Eric Knight; Robert J Glynn; Helen Mogun; Jerry Avorn
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

Review 9.  Medication nonadherence: an unrecognized cardiovascular risk factor.

Authors:  Mark A Munger; Benjamin W Van Tassell; Joanne LaFleur
Journal:  MedGenMed       Date:  2007-09-19

10.  Prescription noncompliance due to cost among adults with disabilities in the United States.

Authors:  Jae Kennedy; Christopher Erb
Journal:  Am J Public Health       Date:  2002-07       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.